Latest Edition Highlights (Issue 39)

Featured articles from our most recent publication

TREATMENTS FOR ACUTE LYMPHOBLASTIC LEUKEMIA: A COMPARISON BETWEEN TISAGENLECLEUCEL AND CLOFARABINE

Background: Acute lymphoblastic leukemia (ALL) is a heterogeneous hematological malignancy predominantly affecting individuals under 20 years of age. Traditional chemotherapy, such as clofarabine, has shown efficacy; however, novel immunotherapeutic strategies like tisagenlecleucel (Kymriah®) have significantly altered the treatment paradigm. Aim: This study aimed to perform a comparative analysis of tisagenlecleucel, a CAR-T cell therapy, and clofarabine, a second-generation purine nucleoside analog, evaluating their mechanisms of action, therapeutic benefits, limitations, and clinical applicability across diverse patient populations. Methods: A systematic comparative evaluation was conducted, encompassing pharmacological characteristics, mechanisms of action, treatment protocols, efficacy, safety profiles, and clinical indications of both agents. The analysis considered pharmacokinetic and pharmacodynamic data and included patient demographic variables. Results: Tisagenlecleucel demonstrated high efficacy in refractory B-cell ALL, with durable responses and a blood half-life of 128 days, but with notable immune-related adverse effects such as cytokine release syndrome. Clofarabine, effective across a broader patient population, acts via multiple antitumor mechanisms but carries significant toxicity risks, including infection and sepsis. Discussion: The therapies present distinct clinical profiles: tisagenlecleucel offers targeted immunotherapy with high specificity but requires specialized infrastructure and management of immune toxicities. Clofarabine is more widely accessible and applicable, but is associated with conventional chemotherapy-related side effects. Treatment accessibility and cost differ markedly between the two. Conclusions: Therapy selection should be personalized based on patient-specific factors and institutional resources. Tisagenlecleucel is ideal for pediatric and young adult patients with relapsed/refractory B-cell ALL in CAR-T-capable centers, while clofarabine remains a viable option for broader ALL populations, particularly when genetic therapies are not feasible. Further research is needed to optimize therapeutic strategies and improve access to advanced treatments.
Read Article

THE REVOLUTION IN AMERICAN PUBLIC HEALTH POLICY: PETROLEUM-BASED DYES AND THE CHRONIC DISEASE EPIDEMIC

Background: The American food regulatory landscape has historically been influenced by industry interests, resulting in the widespread use of petroleum-derived synthetic food dyes banned in European countries. Chronic disease rates in American children have increased from 3% in the 1960s to approximately 60% currently, with annual healthcare costs reaching $1 trillion. The appointment of Robert F. Kennedy Jr. as Secretary of Health and Human Services marks a paradigmatic shift toward transparency and industry accountability in food safety regulation. Aim: This forum analysis examines Kennedy Jr.'s revolutionary approach to food safety regulation, particularly his confrontational stance against petroleum-based food additives exemplified by his statement, "if they want to eat petroleum, they should add it themselves at home" and evaluates the broader implications for American public health policy and global regulatory standards. Methods: Critical analysis of Kennedy Jr.'s public policy statements, examination of epidemiological data trends, and evaluation of proposed regulatory frameworks through content analysis of official speeches and policy declarations from the Department of Health and Human Services. Results: Kennedy Jr.'s administration targets the systematic elimination of synthetic food dyes through industry partnerships, scientific transparency initiatives, and restoration of rigorous research standards. His confrontational rhetorical approach, compared to Mike Tyson's boxing style, has generated unprecedented industry cooperation with food companies "calling almost daily" seeking compliance guidance. The strategy combines voluntary industry agreements with open-source information databases and enhanced FOIA access. Discussion: This confrontational rhetoric represents unprecedented directness in health policy communication, challenging decades of established regulatory practices. The approach prioritizes scientific transparency over diplomatic language, generating both media attention and voluntary industry engagement that traditional regulatory pressure failed to achieve. Conclusions: Kennedy Jr.'s revolutionary stance may establish new global standards for food additive oversight, prioritizing public health over commercial interests through evidence-based policymaking and industry accountability measures. This paradigm shift from reactive to preventive regulatory models could influence international food safety governance and restore American leadership in global health policy.
Read Article

RESEARCH LANDSCAPE OF REPURPOSED MEDICATIONS IN CANCER TREATMENT: A MULTI-DATABASE BIBLIOMETRIC ANALYSIS OF ELEVEN OFF-PATENT THERAPEUTICS

Background: Drug repurposing offers potential advantages for cancer therapy development, particularly when utilizing medications with established safety profiles and expired patents. While individual repurposed medications have been investigated for oncological applications, comprehensive comparative analyses of research distribution patterns across multiple therapeutic candidates appear limited in the literature. Understanding these patterns may provide insights into research priorities and potential knowledge gaps. Aim: This exploratory study was designed to quantify and compare the volume of scientific literature examining the anticancer potential of eleven selected off-patent medications across different pharmacological classes. Methods: Bibliometric searches were conducted across five databases (Google Scholar, BVS, PubMed, NIH, and Science.gov) using standardized search terms combining each medication name with "cancer" and "cancer treatment." The selected medications included ivermectin, fenbendazole, mebendazole, albendazole, metformin, propranolol, disulfiram, valproic acid, thalidomide, dexamethasone, and hydroxychloroquine. Basic statistical analyses were performed to examine the distribution patterns and correlations within the database. Results: The search yielded 3,226,066 total publications with considerable variation in distribution patterns. Dexamethasone accounted for the largest proportion (1,538,058 publications, 47.68%), followed by metformin (697,172 publications, 21.61%). Some medications with smaller overall publication volumes demonstrated higher proportions of treatment-specific research, such as fenbendazole (87.82%), disulfiram with copper (86.54%), and hydroxychloroquine with zinc (75.21%). The Herfindahl Index indicated a high concentration of research attention (0.2870). Discussion: The findings suggest substantial variation in research attention across the selected medications. While some medications dominate the literature, others with focused treatment-specific research may warrant further investigation. The inverse relationship observed between total publication volume and treatment specificity suggests that research patterns in this field may be more complex than absolute publication counts indicate. Conclusions: This preliminary bibliometric assessment reveals an uneven distribution of research attention among repurposed medications being investigated for cancer applications. These patterns may inform future research prioritization, though further qualitative analysis would be valuable to assess the clinical significance of these quantitative observations.
Read Article

General information

SOUTHERN JOURNAL OF SCIENCES

    General information about this journal
  • Title: SOUTHERN JOURNAL OF SCIENCES
  • Short Title: South. J. Sci.
  • ISSN: 2764-5959 (Online); ISSN: 2764-5967 (Print)
  • Universal Decimal Classification (UDC): 001
  • Review Process: Double-Blind Peer-Review
  • Accessibility: Platinum Open Access, NO-APCs.
  • Digital preservation: Portico
  • Frequency of Publication: biannual [2 issues per year]. Journal publication schedule
  • DOI: 10.48141/2764-5959
  • Website: https://www.sjofsciences.com/
  • Country: BRAZIL
  • Publisher: Araucária - Scientific Association.
  • Language of Publication: ENGLISH / PORTUGUESE*
  • *Year that the Journal started accepting manuscripts in Portuguese: 2020
  • First issue year: 1993
  • Free full text: Yes
  • Indexed in: Index Copernicus; Latindex, and I2OR.
  • Formerly known as the Southern Brazilian Journal of Chemistry (1993 to 2021).
  • Former ISSN: 2674-6891 (Online); Former ISSN: 0104-5431 (Print).
  • Website last update: 06/07/2025.

Journal last cover


Last Cover

DOWNLOAD

Selected Articles for Additional Reading (2018 - Present)

Discover more great content from our archive

WITH STRONG PRESENCE AT THE SECOND SOUTHERN SCIENCE CONFERENCE: A HISTORY OF EXCELLENCE IN EDUCATION AND RESEARCH

Background: The Second Southern Science Conference (SSCON 2024) represents a significant milestone in international scientific collaboration, bringing together researchers from twelve nations across multiple continents. The conference, held in Mendoza, Argentina, and co-hosted by the University of Vassouras in Brazil, marked both the 64th anniversary of Universidad de Mendoza and the 20th anniversary of Periódico Tchê Química, demonstrating the growing importance of cross-border academic partnerships. Aim: This study aimed to document and analyze the outcomes and impact of the Second Southern Science Conference, focusing on participation metrics, collaborative patterns, and institutional contributions while highlighting the significance of the hybrid format in facilitating global scientific dialogue. Methods: The analysis involved quantitative assessment of conference participation metrics, including the number of approved papers, author distributions, and institutional representation. The study examined participation patterns across countries and institutions, analyzing collaboration trends through statistical data visualization and comparative analysis of submission rates. Results: The conference achieved significant participation metrics with 65 approved papers and 242 contributing authors, averaging 4 authors per paper. The Universidad Nacional de Córdoba emerged as the leading institution, showcasing its 4 centuries legacy of academic excellence. The analysis revealed strong representation from Latin American institutions, with Brazil and Argentina leading in submissions. Most papers involved 2-5 collaborators, indicating effective research collaboration patterns. Over 500 people participated in the event through both in-person and virtual attendance options. Discussion: The hybrid format successfully facilitated broader international participation and knowledge exchange, which is particularly beneficial for addressing contemporary global challenges. The strong showing from Latin American institutions highlights the region's growing influence in international scientific discourse. The conference's interdisciplinary nature fostered new collaborative initiatives and research partnerships. Conclusions: The conference demonstrated the effectiveness of hybrid international scientific events in fostering global collaboration and knowledge exchange. Areas for improvement were identified, including extended submission timelines and establishment of a permanent management committee. The success of this edition supports the planning of future iterations, with the next edition scheduled to be held in Vassouras, Rio de Janeiro.
Read Article

SURVEY ON KNOWLEDGE OF SEXUALLY TRANSMITTED INFECTIONS AND GONORRHEA: DO WE KNOW ENOUGH?

Background: Sexually Transmitted Infections (STIs) constitute an important group of infections with serious implications for public health. According to WHO, 1 million new contagions are produced daily, with more than 370 million new cases yearly. STIs can be originated from viruses, bacteria, fungi, or parasites. Regardless of their nature, they can be either cured or treated and controlled, but more importantly, they are preventable. Aims: The best tool to fight against STIs is prevention, which has a strong dependence on knowledge. This work aimed to assess the level of knowledge of society about STIs and gonorrhea. Methods: We conducted an online survey, covering a wide range of ages and levels of education, inquiring about areas such as origin, ways of contagion, prevention, associated diseases, and treatment of STIs and gonorrhea. We performed a statistical analysis of the answers. Results and Discussion: it was found that the general level of knowledge about STIs was independent of the age and level of education of the respondents. The respondent has shown better familiarity with prevention and contagion than with origin, diseases, and treatment. When the question was focused on gonorrhea, we found a lack in the cognizance of several points. Conclusions: Based on our findings, we conclude it is necessary to improve sexual education programs, starting at early ages but directed to all populations, particularly about gonorrhea.
Read Article

STUDY ON THE DPPH FREE RADICAL-SCAVENGING ACTIVITY OF SALVIA NEMOROSA L. AT TWO GROWTH STAGES

This study was designed to examine the DPPH free radical-scavenging activity, in different concentrations (0.025, 0.05, 0.07, 0.1, 0.2, 0.04 and 0.6) of methanolic extracts of Salvia nemorosa L. collected from the northwest of Iran (Zonouz and Ardabil regions) at two-stage of growth (vegetative stage leaves, flowering stage leaves, and flowers). The result showed that the mean of inhibition percentage in the Zonouz region increased in various concentrations and between flowers, vegetative stage leaves, and flowering stage leaves, compared with the plants of the Ardabil region. In each of the regions of Zonouz and Ardabil, the highest amount of DPPH inhibition was observed in the vegetative stage leaves in comparison with flowering stage leaves and flowers. In addition, in the effect of DPPH radical trapping in different concentrations of methanolic extracts of Salvia nemorosa L. was observed that from each of the collected region, methanolic extracts from sage plants were dose-dependent and acted very effective and useful and the best antioxidant activity was in the high concentration of extracts, So in Zonouz and Ardabil regions, the content of inhibition of DPPH increased significantly, by increasing the concentration of 0.025 mg/ml to 0.6 mg/ml and in Zonouz region the content of inhibition of DPPH similarly increased in 0.2, 0.4 and 0.6 mg/ml concentrations. In the Ardabil region, the most content of inhibition of DPPH was seen in 0.4 mg/ml and 0.6 mg/ml concentrations, but in this region, the content of inhibition of DPPH in 0.2 mg/ml concentration there was only in vegetative stage leaves and flowering stage leaves.
Read Article

Other relevant news

SOUTHERN JOURNAL OF SCIENCES

The SOUTHERN JOURNAL OF SCIENCES publishes articles in Chemistry, Physics, Mathematics, Biology, Pharmacy, Medicine, Engineering, Industrial Science, Agriculture, and related interdisciplinary areas and is intended to fill a gap in terms of scientific information worldwide. All manuscripts can be published either in English or Portuguese, with tile, abstracts, and keywords in English. At present, there are NO PUBLICATION FEES. Editors will cover web hosting, open access, DOI number, and other service costs.

We have set high standards for the articles to be published by ensuring strong but fair refereeing by at least two reviewers. We hope that this Journal will provide a forum for disseminating high-quality research in chemistry and related areas and are open to any questions and suggestions. Starting in 2020, the SOUTHERN JOURNAL OF SCIENCES will have two issues per year (June and December).

Thank you very much for choosing the SOUTHERN JOURNAL OF SCIENCES to publish your paper!
Editorial Team

THANK YOU FOR YOUR PRESENCE


It was an honor the have you with us.

Last Cover

Crossref Content Registration logo
Portico logo